Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer.
Zinner RG, Fossella FV, Gladish GW, Glisson BS, Blumenschein GR Jr, Papadimitrakopoulou VA, Pisters KM, Kim ES, Oh YW, Peeples BO, Ye Z, Curiel RE, Obasaju CK, Hong WK, Herbst RS.
Zinner RG, et al. Among authors: glisson bs.
Cancer. 2005 Dec 1;104(11):2449-56. doi: 10.1002/cncr.21480.
Cancer. 2005.
PMID: 16258975
Free article.
Clinical Trial.